TITLE:
An Investigational Drug in Patients With Osteoarthritis (0663-073)

CONDITION:
Osteoarthritis

INTERVENTION:
MK0663, etoricoxib

SUMMARY:

      This study was conducted to assess the safety and tolerability of an investigational drug
      and to evaluate its effectiveness in the treatment of osteoarthritis of the hip or knee in
      both men and women.
    

DETAILED DESCRIPTION:

      The duration of treatment is 12 weeks.
    

ELIGIBILITY:
Gender: All
Age: 40 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patients with osteoarthritis of the hip or knee who use current approved medication
             (nonsteroidal anti-inflammatory drugs (NSAIDs)) or tylenol to treat the symptoms of
             their osteoarthritis. Patients taking NSAIDs are required to discontinue using these
             drugs and their symptoms must become worse.

        Exclusion Criteria:

          -  Patients with certain medical conditions may not be allowed to participate. These
             conditions will be reviewed with the study physician.
      
